Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» biosimilars
biosimilars
FDA takes another step to encourage copycat insulin products
Pharmaforum
Wed, 12/18/19 - 10:37 am
FDA
diabetes
insulin
biosimilars
SABCS: Roche's Perjeta builds case as add-on to Herceptin with new analysis
Fierce Pharma
Wed, 12/11/19 - 10:35 am
Roche
breast cancer
Herceptin
Perjeta
biosimilars
SABCS
US biosimilar launches about to turn a corner
Endpoints
Tue, 12/10/19 - 10:07 am
biosimilars
Europe
UCB posts more supportive data from Humira rival bimekizumab
Pharmaforum
Fri, 12/6/19 - 09:31 pm
UCB Pharma
bimekizumab
AbbVie
Humira
psoriasis
biosimilars
US eyes faster launch for biosimilars in North American trade pact; reports
Pharmaforum
Thu, 12/5/19 - 10:17 am
USMCA
trade
biosimilars
Canada
Mexico
FDA guidance finally opens door for insulin biosimilars
Pharmaforum
Mon, 12/2/19 - 09:54 am
FDA
insulin
biosimilars
diabetes
ICER says ‘marginal’ benefits for AbbVie’s new RA drug
Pharmaforum
Sat, 11/30/19 - 11:02 pm
ICER
AbbVie
Rinvoq
rheumatoid arthritis
biosimilars
FDA Updates its Thinking on Immunogenicity Studies for Insulin Biosimilars, Interchangeables
RAPS.org
Tue, 11/26/19 - 09:43 am
FDA
diabetes
insulin
biosimilars
If Biosimilars Are Struggling, Someone Forgot to Tell Coherus BioSciences
Motley Fool
Tue, 11/19/19 - 02:34 pm
biosimilars
FDA
Coherus Biosciences
Neulasta
Amgen
FDA approves latest Humira near-copy, as dozens of biosimilars head for market
Pharmaforum
Mon, 11/18/19 - 10:11 am
FDA
Pfizer
biosimilars
Humira
AbbVie
Abrilada
DEAL WATCH: Biosimilars, Biosimilars and More Biosimilars
Big Molecule Watch
Sun, 11/10/19 - 07:55 pm
biosimilars
Henlius
Ascentage
rituximab
Bioeq
Alvotech
Coherus
Biogen
Samsung Bioepis
Roche escapes lawsuit claiming it illegally quashed Biocad's biosimilar hopes
Fierce Pharma
Thu, 11/7/19 - 11:13 pm
Roche
Biocad
Russia
biosimilars
Say hello to Roche's worst-case scenario: Teva's Rituxan biosim set to launch in U.S.
Fierce Pharma
Thu, 11/7/19 - 11:05 am
Roche
Teva Pharmaceutical
Celltrion
Rituxan
biosimilars
MabThera
Truxima
Biogen signs marketing deal for two ophthalmology biosimilars
Pharmaforum
Thu, 11/7/19 - 10:16 am
Biogen
ophthalmology
biosimilars
Europe
Japan
Samsung Bioepis
SB11
SB15
Lucentis
Eylea
Biogen ups investment in biosimilars
Marketwatch
Wed, 11/6/19 - 10:20 am
Biogen
biosimilars
Samsung Bioepis
It took a 3-year struggle, but Novartis finally gets a green light on their copycat to Amgen's big blockbuster
Endpoints
Tue, 11/5/19 - 10:23 am
Novartis
FDA
Amgen
Neulasta
biosimilars
Ziextenzo
cancer
Under copycat attack, Amgen punches back with its own biosimilars
Fierce Pharma
Tue, 10/29/19 - 10:48 pm
Amgen
biosimilars
generics
Sensipar
Neulasta
Neupogen
New Study Finds Wider Adoption of Biosimilars Could Save States and Taxpayers Billions
BioSpace
Thu, 10/3/19 - 10:24 pm
biosimilars
Samsung Bioepis announces phase 3 results of SB8, Bevacizumab biosimilar candidate, at ESMO 2019 Congress
Pharmaceutical Business Review
Fri, 09/27/19 - 09:34 am
ESMO
Samsung Bioepis
clinical trials
SB8
biosimilars
bevacizumab
non-small cell lung cancer
In U.S. Biosimilars Run Into More Roadblocks
Forbes
Thu, 09/12/19 - 10:38 am
biosimilars
drug development
Pages
« first
‹ previous
…
7
8
9
10
11
12
13
14
15
…
next ›
last »